Baroreflex activation therapy for patients with drug-resistant hypertension

References

• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31(7):1281-357
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117(25):e510-26
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Macca G, Sampieri L, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001;19(11):2063-70
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005;18(11):1422-8
   PubMed Web of Science ®Google Scholar
• Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125(13):1635-42
   PubMed Web of Science ®Google Scholar
• Korner PI. Baroreceptor resetting and other determinants of baroreflex properties in hypertension. Clin Exp Pharmacol Physiol Suppl 1989;15:45-64
   Google Scholar
• Meguro Y, Miura Y, Kimura S, et al. A sympathetic component of baroreflex function in patients with essential hypertension. Clin Exp Pharmacol Physiol Suppl 1989;15:93-5
   Google Scholar
• Head GA. Cardiac baroreflexes and hypertension. Clin Exp Pharmacol Physiol 1994;21(10):791-802
   Google Scholar
• Stern JE, Sonner PM, Son SJ, et al. Exercise training normalizes an increased neuronal excitability of NTS-projecting neurons of the hypothalamic paraventricular nucleus in hypertensive rats. J Neurophysiol 2012;107(10):2912-21
   Google Scholar
• Dimeo F, Pagonas N, Seibert F, et al. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension 2012;60(3):653-8
   PubMed Web of Science ®Google Scholar
• Joseph CN, Porta C, Casucci G, et al. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension 2005;46(4):714-18
   Google Scholar
• Scheffers IJ, Kroon AA, de Leeuw PW. Carotid baroreflex activation: past, present, and future. Curr Hypertens Rep 2010;12(2):61-6
   PubMed Web of Science ®Google Scholar
• Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011;57(6):1076-80
   PubMed Web of Science ®Google Scholar
• Scheffers IJ, Kroon AA, Tordoir JH, de Leeuw PW. Rheos baroreflex hypertension therapy system to treat resistant hypertension. Expert Rev Med Devices 2008;5(1):33-9
   PubMed Web of Science ®Google Scholar
• Tordoir JH, Scheffers I, Schmidli J, et al. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007;33(4):414-21
   PubMed Web of Science ®Google Scholar
• Furlan R, Diedrich A, Rimoldi A, et al. Effects of unilateral and bilateral carotid baroreflex stimulation on cardiac and neural sympathetic discharge oscillatory patterns. Circulation 2003;108(6):717-23
   Google Scholar
• Hoppe UC, Brandt MC, Wachter R, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens 2012;6(4):270-6
   PubMed Web of Science ®Google Scholar
• Chapleau MW, Hajduczok G, Abboud FM. Peripheral and central mechanisms of baroreflex resetting. Clin Exp Pharmacol Physiol Suppl 1989;15:31-43
   PubMedGoogle Scholar
• Richter DW, Keck W, Seller H. The course of inhibition of sympathetic activity during various patterns of carotid sinus nerve stimulation. Pflugers Arch 1970;317(2):110-23
   Google Scholar
• Chapleau MW, Hajduczok G, Abboud FM. Pulsatile activation of baroreceptors causes central facilitation of baroreflex. Am J Physiol 1989;256(6 Pt 2):H1735-41
   PubMedGoogle Scholar
• Bakris GL, Nadim MK, Haller H, et al. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 2012;6(2):152-8
   Google Scholar
• Dunning AJ. Electrostimulation of the carotid sinus nerve in angina pectoris. University Department of Medicine; Binnengasthuis, Amsterdam: 1972. p. 61-89
   Google Scholar
• Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010;55(3):619-26
   PubMed Web of Science ®Google Scholar
• Sleight P. The importance of the autonomic nervous system in health and disease. Aust N Z J Med 1997;27(4):467-73
   Google Scholar
• Thrasher TN. Baroreceptors, baroreceptor unloading, and the long-term control of blood pressure. Am J Physiol Regul Integr Comp Physiol 2005;288(4):R819-27
   PubMed Web of Science ®Google Scholar
• Iliescu R, Lohmeier TE. Mechanisms of blood pressure reduction by prolonged activation of the baroreflex. Annual International Conference of the IEEE, Engineering in Medicine and Biology Society; Minneapolis, MN, USA; 2009. p. 2040-2
   Google Scholar
• Lohmeier TE, Dwyer TM, Irwin ED, et al. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2007;49(6):1307-14
   PubMed Web of Science ®Google Scholar
• Iliescu R, Irwin ED, Georgakopoulos D, Lohmeier TE. Renal responses to chronic suppression of central sympathetic outflow. Hypertension 2012;60(3):749-56
   Google Scholar
• Wustmann K, Kucera JP, Scheffers I, et al. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 2009;54(3):530-6
   PubMed Web of Science ®Google Scholar
• Alnima T, Scheffers I, De Leeuw PW, et al. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens 2012;30(8):1665-70
   Google Scholar
• Krieger EM. Arterial baroreceptor resetting in hypertension (the J. W. McCubbin memorial lecture). Clin Exp Pharmacol Physiol Suppl 1989;15:3-17
   Google Scholar
• Andresen MC, Yang M. Arterial baroreceptor resetting: contributions of chronic and acute processes. Clin Exp Pharmacol Physiol Suppl 1989;15:19-30
   Google Scholar
• Lohmeier TE, Hildebrandt DA, Dwyer TM, et al. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension 2007;49(2):373-9
   Google Scholar
• Antunes-Rodrigues J, Machado BH, Andrade HA, et al. Carotid-aortic and renal baroreceptors mediate the atrial natriuretic peptide release induced by blood volume expansion. Proc Natl Acad Sci USA 1992;89(15):6828-31
   PubMedGoogle Scholar
• Schmidli J, Savolainen H, Eckstein F, et al. Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular 2007;15(2):63-9
   Google Scholar
• Scheffers IJ, Kroon AA, Schmidli J, et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 2010;56(15):1254-8
   PubMed Web of Science ®Google Scholar
• Bisognano JD, Bakris G, Nadim MK, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos pivotal trial. J Am Coll Cardiol 2011;58(7):765-73
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Tsiachris D, Papademetriou V, Stefanadis C. Baroreflex activation therapy and resistant hypertension randomization is not enough, you should measure blood pressure appropriately. J Am Coll Cardiol 2012;59(5):541
   Google Scholar
• Alnima T, de Leeuw PW, Tan FE, et al. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension. Hypertension 2013;61(6):1334-9
   Google Scholar
• Robertson D, Hollister AS, Biaggioni I, et al. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993;329(20):1449-55
   Google Scholar
• Furlan R, Porta A, Costa F, et al. Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus. Circulation 2000;101(8):886-92
   PubMed Web of Science ®Google Scholar
• Scheffers I. Carotid baroreflex activation. A novel method to treat resistant hypertension. Department of Internal Medicine, University of Maastricht; Maastricht, Netherlands: 2010. Chapter 7
   Google Scholar
• Borisenko O, Beige J, Lovett EG, et al. Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings. J Hypertens 2014;32(3):681-92
   Google Scholar
• Bhatt DL, Kandzari DE, O’Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370(15):1393-401
   PubMed Web of Science ®Google Scholar
• Peter DA, Alemu Y, Xenos M, et al. Fluid structure interaction with contact surface methodology for evaluation of endovascular carotid implants for drug-resistant hypertension treatment. J Biomech Eng 2012;134(4):041001
   PubMed Web of Science ®Google Scholar
• Green AL, Wang S, Owen SL, et al. Deep brain stimulation can regulate arterial blood pressure in awake humans. Neuroreport 2005;16(16):1741-5
   Google Scholar
• Green AL, Wang S, Bittar RG, et al. Deep brain stimulation: a new treatment for hypertension? J Clin Neurosci 2007;14(6):592-5
   Google Scholar
• Pereira EA, Wang S, Paterson DJ, et al. Sustained reduction of hypertension by deep brain stimulation. J Clin Neurosci 2010;17(1):124-7
   Google Scholar
• Carter HH, Dawson EA, Cable NT, et al. Deep brain stimulation of the periaqueductal grey induces vasodilation in humans. Hypertension 2011;57(5):e24-5
   Google Scholar
• Sverrisdottir YB, Green AL, Aziz TZ, et al. Differentiated baroreflex modulation of sympathetic nerve activity during deep brain stimulation in humans. Hypertension 2014;63(5):1000-10
   PubMed Web of Science ®Google Scholar
• Abdala AP, McBryde FD, Marina N, et al. Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. J Physiol 2012;590(Pt 17):4269-77
   PubMed Web of Science ®Google Scholar
• McBryde FD, Abdala AP, Hendy EB, et al. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun 2013;4:2395
   PubMed Web of Science ®Google Scholar